Global Car T Therapy Market Research Report 2025(Status and Outlook)
Description
Report Overview
CAR-T (Chimeric Antigen Receptor T-cell) therapy is a revolutionary form of immunotherapy that involves genetically modifying a patient's own T-cells to recognize and attack cancer cells. The process begins with extracting T-cells from the patient, engineering them to express a specific receptor (CAR) that targets an antigen on cancer cells, and then reinfusing them back into the patient to enhance the immune system's ability to destroy malignant cells. Primarily used in hematologic malignancies like B-cell leukemias and lymphomas, CAR-T therapy has shown remarkable efficacy in treating relapsed or refractory cancers. However, its application in solid tumors remains challenging due to factors like the tumor microenvironment and antigen heterogeneity. The therapy is highly personalized, complex to manufacture, and often associated with severe side effects such as cytokine release syndrome (CRS) and neurotoxicity, requiring specialized clinical management. Despite these hurdles, CAR-T therapy represents a groundbreaking advancement in oncology, offering a potentially curative option for patients with limited treatment alternatives. The global CAR-T therapy market is rapidly expanding, driven by increasing cancer prevalence, advancements in cell therapy technology, and strong clinical trial results. As of recent estimates, the market is valued in the billions and is projected to grow at a double-digit CAGR over the next decade. Key players include Novartis (Kymriah), Gilead (Yescarta and Tecartus), Bristol Myers Squibb (Breyanzi and Abecma), and Johnson & Johnson (Carvykti), with ongoing R&D focused on improving efficacy, reducing toxicity, and expanding indications beyond blood cancers. North America dominates the market due to robust healthcare infrastructure, favorable reimbursement policies, and high adoption rates, followed by Europe and Asia-Pacific, where regulatory approvals and investments in CAR-T manufacturing facilities are accelerating growth. However, high treatment costs (often exceeding $300,000 per patient) and logistical challenges in cell processing and delivery remain significant barriers. Emerging trends include allogeneic (off-the-shelf) CAR-T therapies, dual-targeting CAR constructs, and combination therapies with checkpoint inhibitors. With increasing partnerships between biotech firms and academic institutions, as well as regulatory incentives for orphan drug designations, CAR-T therapy is poised to reshape the oncology landscape, though affordability and accessibility will be critical for broader adoption.
The global Car T Therapy market size was estimated at USD 1051.16 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 22.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Car T Therapy market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Car T Therapy market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Car T Therapy market.
Global Car T Therapy Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Novartis AG
Kite Pharma
Pfizer
Juno Therapeutics
Celgene Corporation
CARsgen Therapeutics
Sorrento Therapeutics
Legend Biotech
Atara Biotherapeutics
Aurora Biopharma
Autolus Therapeutics PLC
Bluebird
Carina Biotech
Market Segmentation (by Type)
CD19
CD22
Other
Market Segmentation (by Application)
Acute Lymphocytic Leukemia
Diffuse Large B Cell Lymphoma
Follicular Lymphoma
Chronic Lymphocytic Leukemia
Multiple Myeloma
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Car T Therapy Market
Overview of the regional outlook of the Car T Therapy Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Car T Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Car T Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
CAR-T (Chimeric Antigen Receptor T-cell) therapy is a revolutionary form of immunotherapy that involves genetically modifying a patient's own T-cells to recognize and attack cancer cells. The process begins with extracting T-cells from the patient, engineering them to express a specific receptor (CAR) that targets an antigen on cancer cells, and then reinfusing them back into the patient to enhance the immune system's ability to destroy malignant cells. Primarily used in hematologic malignancies like B-cell leukemias and lymphomas, CAR-T therapy has shown remarkable efficacy in treating relapsed or refractory cancers. However, its application in solid tumors remains challenging due to factors like the tumor microenvironment and antigen heterogeneity. The therapy is highly personalized, complex to manufacture, and often associated with severe side effects such as cytokine release syndrome (CRS) and neurotoxicity, requiring specialized clinical management. Despite these hurdles, CAR-T therapy represents a groundbreaking advancement in oncology, offering a potentially curative option for patients with limited treatment alternatives. The global CAR-T therapy market is rapidly expanding, driven by increasing cancer prevalence, advancements in cell therapy technology, and strong clinical trial results. As of recent estimates, the market is valued in the billions and is projected to grow at a double-digit CAGR over the next decade. Key players include Novartis (Kymriah), Gilead (Yescarta and Tecartus), Bristol Myers Squibb (Breyanzi and Abecma), and Johnson & Johnson (Carvykti), with ongoing R&D focused on improving efficacy, reducing toxicity, and expanding indications beyond blood cancers. North America dominates the market due to robust healthcare infrastructure, favorable reimbursement policies, and high adoption rates, followed by Europe and Asia-Pacific, where regulatory approvals and investments in CAR-T manufacturing facilities are accelerating growth. However, high treatment costs (often exceeding $300,000 per patient) and logistical challenges in cell processing and delivery remain significant barriers. Emerging trends include allogeneic (off-the-shelf) CAR-T therapies, dual-targeting CAR constructs, and combination therapies with checkpoint inhibitors. With increasing partnerships between biotech firms and academic institutions, as well as regulatory incentives for orphan drug designations, CAR-T therapy is poised to reshape the oncology landscape, though affordability and accessibility will be critical for broader adoption.
The global Car T Therapy market size was estimated at USD 1051.16 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 22.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Car T Therapy market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Car T Therapy market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Car T Therapy market.
Global Car T Therapy Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Novartis AG
Kite Pharma
Pfizer
Juno Therapeutics
Celgene Corporation
CARsgen Therapeutics
Sorrento Therapeutics
Legend Biotech
Atara Biotherapeutics
Aurora Biopharma
Autolus Therapeutics PLC
Bluebird
Carina Biotech
Market Segmentation (by Type)
CD19
CD22
Other
Market Segmentation (by Application)
Acute Lymphocytic Leukemia
Diffuse Large B Cell Lymphoma
Follicular Lymphoma
Chronic Lymphocytic Leukemia
Multiple Myeloma
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Car T Therapy Market
Overview of the regional outlook of the Car T Therapy Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Car T Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Car T Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Table of Contents
147 Pages
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Car T Therapy
- 1.2 Key Market Segments
- 1.2.1 Car T Therapy Segment by Type
- 1.2.2 Car T Therapy Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Car T Therapy Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Car T Therapy Market Size (M USD) Estimates and Forecasts (2020-2033)
- 2.1.2 Global Car T Therapy Sales Estimates and Forecasts (2020-2033)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Car T Therapy Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Car T Therapy Product Life Cycle
- 3.3 Global Car T Therapy Sales by Manufacturers (2020-2025)
- 3.4 Global Car T Therapy Revenue Market Share by Manufacturers (2020-2025)
- 3.5 Car T Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.6 Global Car T Therapy Average Price by Manufacturers (2020-2025)
- 3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
- 3.8 Car T Therapy Market Competitive Situation and Trends
- 3.8.1 Car T Therapy Market Concentration Rate
- 3.8.2 Global 5 and 10 Largest Car T Therapy Players Market Share by Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 Car T Therapy Industry Chain Analysis
- 4.1 Car T Therapy Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Car T Therapy Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 PEST Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global Car T Therapy Market Porter's Five Forces Analysis
- 5.6.1 Global Trade Frictions
- 5.6.2 U.S. Tariff Policy – April 2025
- 5.6.3 Global Trade Frictions and Their Impacts to Car T Therapy Market
- 5.7 ESG Ratings of Leading Companies
- 6 Car T Therapy Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Car T Therapy Sales Market Share by Type (2020-2025)
- 6.3 Global Car T Therapy Market Size Market Share by Type (2020-2025)
- 6.4 Global Car T Therapy Price by Type (2020-2025)
- 7 Car T Therapy Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Car T Therapy Market Sales by Application (2020-2025)
- 7.3 Global Car T Therapy Market Size (M USD) by Application (2020-2025)
- 7.4 Global Car T Therapy Sales Growth Rate by Application (2020-2025)
- 8 Car T Therapy Market Sales by Region
- 8.1 Global Car T Therapy Sales by Region
- 8.1.1 Global Car T Therapy Sales by Region
- 8.1.2 Global Car T Therapy Sales Market Share by Region
- 8.2 Global Car T Therapy Market Size by Region
- 8.2.1 Global Car T Therapy Market Size by Region
- 8.2.2 Global Car T Therapy Market Size Market Share by Region
- 8.3 North America
- 8.3.1 North America Car T Therapy Sales by Country
- 8.3.2 North America Car T Therapy Market Size by Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe Car T Therapy Sales by Country
- 8.4.2 Europe Car T Therapy Market Size by Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Car T Therapy Sales by Region
- 8.5.2 Asia Pacific Car T Therapy Market Size by Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America Car T Therapy Sales by Country
- 8.6.2 South America Car T Therapy Market Size by Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East and Africa
- 8.7.1 Middle East and Africa Car T Therapy Sales by Region
- 8.7.2 Middle East and Africa Car T Therapy Market Size by Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 UAE Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 9 Car T Therapy Market Production by Region
- 9.1 Global Production of Car T Therapy by Region(2020-2025)
- 9.2 Global Car T Therapy Revenue Market Share by Region (2020-2025)
- 9.3 Global Car T Therapy Production, Revenue, Price and Gross Margin (2020-2025)
- 9.4 North America Car T Therapy Production
- 9.4.1 North America Car T Therapy Production Growth Rate (2020-2025)
- 9.4.2 North America Car T Therapy Production, Revenue, Price and Gross Margin (2020-2025)
- 9.5 Europe Car T Therapy Production
- 9.5.1 Europe Car T Therapy Production Growth Rate (2020-2025)
- 9.5.2 Europe Car T Therapy Production, Revenue, Price and Gross Margin (2020-2025)
- 9.6 Japan Car T Therapy Production (2020-2025)
- 9.6.1 Japan Car T Therapy Production Growth Rate (2020-2025)
- 9.6.2 Japan Car T Therapy Production, Revenue, Price and Gross Margin (2020-2025)
- 9.7 China Car T Therapy Production (2020-2025)
- 9.7.1 China Car T Therapy Production Growth Rate (2020-2025)
- 9.7.2 China Car T Therapy Production, Revenue, Price and Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 Novartis AG
- 10.1.1 Novartis AG Basic Information
- 10.1.2 Novartis AG Car T Therapy Product Overview
- 10.1.3 Novartis AG Car T Therapy Product Market Performance
- 10.1.4 Novartis AG Business Overview
- 10.1.5 Novartis AG SWOT Analysis
- 10.1.6 Novartis AG Recent Developments
- 10.2 Kite Pharma
- 10.2.1 Kite Pharma Basic Information
- 10.2.2 Kite Pharma Car T Therapy Product Overview
- 10.2.3 Kite Pharma Car T Therapy Product Market Performance
- 10.2.4 Kite Pharma Business Overview
- 10.2.5 Kite Pharma SWOT Analysis
- 10.2.6 Kite Pharma Recent Developments
- 10.3 Pfizer
- 10.3.1 Pfizer Basic Information
- 10.3.2 Pfizer Car T Therapy Product Overview
- 10.3.3 Pfizer Car T Therapy Product Market Performance
- 10.3.4 Pfizer Business Overview
- 10.3.5 Pfizer SWOT Analysis
- 10.3.6 Pfizer Recent Developments
- 10.4 Juno Therapeutics
- 10.4.1 Juno Therapeutics Basic Information
- 10.4.2 Juno Therapeutics Car T Therapy Product Overview
- 10.4.3 Juno Therapeutics Car T Therapy Product Market Performance
- 10.4.4 Juno Therapeutics Business Overview
- 10.4.5 Juno Therapeutics Recent Developments
- 10.5 Celgene Corporation
- 10.5.1 Celgene Corporation Basic Information
- 10.5.2 Celgene Corporation Car T Therapy Product Overview
- 10.5.3 Celgene Corporation Car T Therapy Product Market Performance
- 10.5.4 Celgene Corporation Business Overview
- 10.5.5 Celgene Corporation Recent Developments
- 10.6 CARsgen Therapeutics
- 10.6.1 CARsgen Therapeutics Basic Information
- 10.6.2 CARsgen Therapeutics Car T Therapy Product Overview
- 10.6.3 CARsgen Therapeutics Car T Therapy Product Market Performance
- 10.6.4 CARsgen Therapeutics Business Overview
- 10.6.5 CARsgen Therapeutics Recent Developments
- 10.7 Sorrento Therapeutics
- 10.7.1 Sorrento Therapeutics Basic Information
- 10.7.2 Sorrento Therapeutics Car T Therapy Product Overview
- 10.7.3 Sorrento Therapeutics Car T Therapy Product Market Performance
- 10.7.4 Sorrento Therapeutics Business Overview
- 10.7.5 Sorrento Therapeutics Recent Developments
- 10.8 Legend Biotech
- 10.8.1 Legend Biotech Basic Information
- 10.8.2 Legend Biotech Car T Therapy Product Overview
- 10.8.3 Legend Biotech Car T Therapy Product Market Performance
- 10.8.4 Legend Biotech Business Overview
- 10.8.5 Legend Biotech Recent Developments
- 10.9 Atara Biotherapeutics
- 10.9.1 Atara Biotherapeutics Basic Information
- 10.9.2 Atara Biotherapeutics Car T Therapy Product Overview
- 10.9.3 Atara Biotherapeutics Car T Therapy Product Market Performance
- 10.9.4 Atara Biotherapeutics Business Overview
- 10.9.5 Atara Biotherapeutics Recent Developments
- 10.10 Aurora Biopharma
- 10.10.1 Aurora Biopharma Basic Information
- 10.10.2 Aurora Biopharma Car T Therapy Product Overview
- 10.10.3 Aurora Biopharma Car T Therapy Product Market Performance
- 10.10.4 Aurora Biopharma Business Overview
- 10.10.5 Aurora Biopharma Recent Developments
- 10.11 Autolus Therapeutics PLC
- 10.11.1 Autolus Therapeutics PLC Basic Information
- 10.11.2 Autolus Therapeutics PLC Car T Therapy Product Overview
- 10.11.3 Autolus Therapeutics PLC Car T Therapy Product Market Performance
- 10.11.4 Autolus Therapeutics PLC Business Overview
- 10.11.5 Autolus Therapeutics PLC Recent Developments
- 10.12 Bluebird
- 10.12.1 Bluebird Basic Information
- 10.12.2 Bluebird Car T Therapy Product Overview
- 10.12.3 Bluebird Car T Therapy Product Market Performance
- 10.12.4 Bluebird Business Overview
- 10.12.5 Bluebird Recent Developments
- 10.13 Carina Biotech
- 10.13.1 Carina Biotech Basic Information
- 10.13.2 Carina Biotech Car T Therapy Product Overview
- 10.13.3 Carina Biotech Car T Therapy Product Market Performance
- 10.13.4 Carina Biotech Business Overview
- 10.13.5 Carina Biotech Recent Developments
- 11 Car T Therapy Market Forecast by Region
- 11.1 Global Car T Therapy Market Size Forecast
- 11.2 Global Car T Therapy Market Forecast by Region
- 11.2.1 North America Market Size Forecast by Country
- 11.2.2 Europe Car T Therapy Market Size Forecast by Country
- 11.2.3 Asia Pacific Car T Therapy Market Size Forecast by Region
- 11.2.4 South America Car T Therapy Market Size Forecast by Country
- 11.2.5 Middle East and Africa Forecasted Sales of Car T Therapy by Country
- 12 Forecast Market by Type and by Application (2026-2033)
- 12.1 Global Car T Therapy Market Forecast by Type (2026-2033)
- 12.1.1 Global Forecasted Sales of Car T Therapy by Type (2026-2033)
- 12.1.2 Global Car T Therapy Market Size Forecast by Type (2026-2033)
- 12.1.3 Global Forecasted Price of Car T Therapy by Type (2026-2033)
- 12.2 Global Car T Therapy Market Forecast by Application (2026-2033)
- 12.2.1 Global Car T Therapy Sales (K Units) Forecast by Application
- 12.2.2 Global Car T Therapy Market Size (M USD) Forecast by Application (2026-2033)
- 13 Conclusion and Key Findings
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
